Category

Family Office Networks Webinar Series
Background on Company Novel scientific insights to unlock the full potential of B cell therapeutics Range of treatment opportunities for cancer immunotherapy and B cell-driven rare diseases Lead program, AT-1965, advancing toward IND and initiation of solid tumor clinical study in 2H2020 Positive pre-IND interaction with FDA; alignment on 2020 IND submission and clinical initiation...
Read More
Join the Family Office Networks Webinar Series Featuring Hemptown USA. Eric Gripentrog, CEO will discuss hemp derived cannabinoids, including CBD and CBG, and the platform that Hemptown USA has built for industry consolidation and integration. Hemptown is a leader in cultivation with a Fortune 500 management team, including leadership from Kellogg and Intel. It is...
Read More
Come Join the Family Office Networks Webinar Series featuring Impact Venture Capital. Eric Ball, General Partner with Impact will lead a panel discussion that will include Michael Beaudoin of Mark IV Capital and Victoria Cheng of Citi Ventures. Impact Venture Capital is an early-stage firm that partners with top corporate venture arms to invest in...
Read More
Come join the Family Office Networks Webinar Series Featuring CLICS. CLICS is the first digital hair color studio for stylists and pay per dispense color service for salons. Charles Brown, CEO will discuss the future of color formulation with millions of designable and repeatable colors using the Neural Net Al Solution.
Read More
Genprex, Inc is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. What they will learn from this webinar How Genprex is...
Read More
In recent years, “sustainable investing”— meaning investment strategies that incorporate environmental, social, and governance (ESG) factors alongside traditional financial analysis — has grown considerably in attention and assets under management (AUM). According to a 2018 study, more than $12 trillion in assets in the U.S. alone were managed in a sustainable process, compared to $639...
Read More
Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for...
Read More
Come join the Family Office Networks community and the management team from OXIO Health, Inc. (OXIO) as they discuss solutions to the current healthcare crisis and the multiple opportunities they have created with industry leadership that brings an outstanding investment opportunity with High Societal Impact. OXIO is the parent company of an initial group of...
Read More
Exro Technologies
Exro Technologies is a software design company that creates an Electric Program Module (EPM), effectively a computer chip that communicates directly with an electric motor and powertrain. Sue Ozdemir, CEO will discuss how Exro technology makes existing electric motors smarter and more efficient. Simplifyy is drastically reducing owner's operating costs through the implementation of our...
Read More
The first modern approach to multifamily property management. By combining people and software in one easy solution, Simplifyy eliminates waste and help owners make more and stress less, guaranteed. Simplifyy is drastically reducing owner's operating costs through the implementation of our software and service platform, which eliminates office payroll, administrative, advertising and marketing, and management...
Read More
1 2 3 5